Treatment with acmopatide (CT-868), a dual glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonist (GLP-1/GIP RA), improved glycemic management while reducing weight, insulin dose, and blood pressure in a phase 2 clinical trial of adults living with type 1 diabetes and obesity
The pre-bed injection is widely considered the most important administration window, as it amplifies the body's largest natural GH pulse during deep sleep
Acetyl-l-carnitine has also been shown to protect nerve cells against free radical damage, support cellular glutathione production, promote healthy CoQ10 levels and offer special protection to healthy brain cells
Gastrointestinal effects are common with Saxenda, particularly during dose titration
Adequate water intake, fiber supplementation, and occasional use of gentle laxatives manage this for most people
We recommend a varied, balanced diet and a healthy lifestyle